Healthy Returns: J&J, Merck and Bristol Myers Squibb are in the hot seat
Publishing timestamp: 2024-01-30 13:52:54
Summary
The article discusses the upcoming Senate hearing on high prescription drug prices, where CEOs from Johnson & Johnson, Merck, and Bristol Myers Squibb will testify. These companies manufacture some of the most expensive drugs in the US. The article also mentions the Medicare drug price negotiations and the challenges faced by the pharmaceutical companies due to upcoming patent expirations. Additionally, it mentions Apple's launch of its mixed reality headset, Vision Pro, and its potential use in healthcare. Lastly, the article briefly mentions the author's experience testing a continuous glucose monitor from startup Signos.
Sentiment: MIXED
Keywords: health care industry, bristol-myers squibb co, biotech and pharmaceuticals, merck & co inc, johnson & johnson, united states, business news,